KTC
RXII

Kistler-Tiffany Companies’s GALENA BIOPHARMA INC COM RXII Stock Holding History

Kistler-Tiffany Companies’s Portfolio RXII Stock Details RXII Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-2,261
Closed -$3K – 647
2014
Q4 		$3K Hold
2,261
– – ﹤0.01% 528
2014
Q3 		$5K Hold
2,261
– – ﹤0.01% 519
2014
Q2 		$7K Hold
2,261
– – 0.01% 473
2014
Q1 		$6K Hold
2,261
– – ﹤0.01% 478
2013
Q4 		$11K Hold
2,261
– – 0.01% 424
2013
Q3 		$5K Hold
2,261
– – ﹤0.01% 496
2013
Q2 		$5K Buy
+2,261
New +$5K ﹤0.01% 495

Other funds holding RXII

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
HCMT
Highland Capital Management (Texas) Dallas, Texas $39M AUM
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Kistler-Tiffany Companies's RXII Position: Q1 2015 in Review

Kistler-Tiffany Companies sold out of GALENA BIOPHARMA INC COM (RXII) in Q1 2015, closing a stake of 2,261 shares — an estimated $3K sold.

Kistler-Tiffany Companies first reported a position in RXII in Q2 2013 and held it in 7 quarters. The position peaked at $11K in Q4 2013. 87 funds tracked by Wall St. Rank hold RXII as of Q1 2015.

  • Kistler-Tiffany Companies reported no remaining GALENA BIOPHARMA INC COM position as of Q1 2015 after selling out during the quarter.
  • Kistler-Tiffany Companies sold 2,261 GALENA BIOPHARMA INC COM shares in Q1 2015, an estimated $3K.
  • Kistler-Tiffany Companies first reported a position in GALENA BIOPHARMA INC COM in Q2 2013 and held it in 7 quarters.
  • Kistler-Tiffany Companies's GALENA BIOPHARMA INC COM position peaked at $11K in Q4 2013.
  • 87 funds tracked by Wall St. Rank held GALENA BIOPHARMA INC COM as of Q1 2015.

Based on Kistler-Tiffany Companies's 13F filing for Q1 2015, filed 6 May 2015.